Trexquant Investment LP Aveo Pharmaceuticals, Inc. Transaction History

Trexquant Investment LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$8.48 - $14.97 $399,662 - $705,536	47,130 Added 176.06%	73,900 $1.1 Million
Q3 2022 Nov 14, 2022	BUY	$6.61 - $8.72 $176,949 - $233,434	26,770 New	26,770 $220,000
Q1 2021 May 13, 2021	SELL	$5.97 - $15.28 $387,082 - $990,724	-64,838 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$5.08 - $6.68 $239,745 - $315,255	47,194 Added 267.48%	64,838 $374,000
Q3 2020 Nov 06, 2020	BUY	$4.16 - $6.26 $73,399 - $110,451	17,644 New	17,644 $105,000

Ticker AVEO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,676,000
Description
AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the ...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.